As the 2025 influenza season wraps up in the Southern Hemisphere, the Northern Hemisphere braces for its turn—and this is where things get critical. The Pan American Health Organization (PAHO) and the World Health Organization (WHO) are sounding the alarm, urging countries to gear up for a potential surge in respiratory viruses, including influenza, respiratory syncytial virus (RSV), and SARS-CoV-2. But here’s where it gets controversial: while many focus on COVID-19, RSV and seasonal flu often fly under the radar—yet they can be just as devastating, especially for vulnerable populations. PAHO/WHO emphasizes the need for a multi-pronged strategy: ramping up surveillance to detect outbreaks early, ensuring healthcare systems are ready for a possible overload, and prioritizing vaccination for high-risk groups. But is our current approach enough? While vaccination campaigns are crucial, the organizations also stress the importance of early diagnosis, proper clinical management, and adequate supplies of antivirals and personal protective equipment. And this is the part most people miss: effective risk communication is key—both to the public and healthcare professionals. Without clear, consistent messaging, even the best preparedness plans can fall short. So, as we head into this new season, the question remains: Are we truly prepared, or are we overlooking critical gaps? Let’s discuss—what do you think is the most overlooked aspect of respiratory virus preparedness? Share your thoughts in the comments!
